WETS
AGIO icon

Wealth Enhancement Trust Services’s Agios Pharmaceuticals AGIO Stock Holding History

Wealth Enhancement Trust Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Buy
+77
New +$2.34K ﹤0.01% 943

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealth Enhancement Trust Services's AGIO Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 77 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #943 among its holdings.

152 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Wealth Enhancement Trust Services held 77 shares of Agios Pharmaceuticals worth $2.86K as of Q2 2026.
  • Agios Pharmaceuticals was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #943 holding.
  • 152 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.